Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl

Abstract Background In response to greater illicit fentanyl use, buprenorphine daily doses exceeding the FDA’s recommended target daily dose (16 mg) and maximum suggested daily dose (24 mg) may provide better outcomes, but little is known about higher dosage prescribing patterns. To better understan...

Full description

Bibliographic Details

Published in:	Addiction Science & Clinical Practice
Main Authors:	Bradley D. Stein, Flora Sheng, Brendan K. Saloner, Adam J. Gordon, Jessica S. Merlin
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Subjects:	Opioid use disorder Buprenorphine Insurance
Online Access:	https://doi.org/10.1186/s13722-025-00547-0